ARKAY MARIE LISING: Open Payments
NPI 1689259798 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,085 in 29 payments from 7 companies in 2025. Trend: 2023 $160 · 2024 $744 · 2025 $1,085
Food & beverage: $1,085
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $449 |
| ABBVIE INC. | 5 | $263 |
| Vanda Pharmaceuticals Inc. | 3 | $176 |
| Otsuka America Pharmaceutical, Inc. | 4 | $84 |
| Axsome Therapeutics, Inc. | 3 | $55 |
| Supernus Pharmaceuticals, Inc. | 2 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
Products named: CAPLYTA, VRAYLAR, FANAPT, REXULTI, Auvelity, Qelbree, COBENFY.
Industry payments across NV — which companies pay providers there.
